TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery

Liver resection is the treatment of choice in patients with malignant liver lesions. Unfortunately, the surgery is not always an option, as in same patients the future remnant liver (FRL) is too small to supply all the functions. Therefore, some additional methods have been proposed to increase the size of the FRL. The aim of this study is to compare the efficacy and safety of three methods of increasing the future remnant liver - Portal Vein Embolization (PVE) - embolization of one of the portal branches; Liver Vein Deprivation (LVD) - embolization both of the portal branch as well as the he

Trial Details

NCT ID
NCT06050200
Phase
NA
Sponsor
Medical University of Warsaw
Status
RECRUITING
Cancer Type
Liver Cancer
Interventions
  • PVE
  • LVD
  • ALPPS
Locations (sample)
  • Warsaw, Masovian Voivodeship, Poland|52.22977,21.01178

Key Eligibility Criteria

  • age \>= 18 years
  • patients qualified for liver resection
  • future remnant liver \<30% of standard liver volume
  • written informed consent

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Liver Cancer Trials on Trialify →